ZhuZhou QianJin Pharmaceutical Co Ltd (600479) - Total Assets
Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) holds total assets worth CN¥4.90 Billion CNY (≈ $717.16 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 600479 total equity for net asset value and shareholders' equity analysis.
ZhuZhou QianJin Pharmaceutical Co Ltd - Total Assets Trend (2001–2024)
This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.
ZhuZhou QianJin Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
ZhuZhou QianJin Pharmaceutical Co Ltd's total assets of CN¥4.90 Billion consist of 59.9% current assets and 40.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.5% |
| Accounts Receivable | CN¥839.09 Million | 18.4% |
| Inventory | CN¥485.94 Million | 10.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥236.83 Million | 5.2% |
| Goodwill | CN¥14.07 Million | 0.3% |
Asset Composition Trend (2001–2024)
This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ZhuZhou QianJin Pharmaceutical Co Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ZhuZhou QianJin Pharmaceutical Co Ltd's current assets represent 59.9% of total assets in 2024, a decrease from 74.9% in 2001.
- Cash Position: Cash and equivalents constituted 29.5% of total assets in 2024, up from 28.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 1.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 18.4% of total assets.
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of ZhuZhou QianJin Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥21.15 Billion |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
India | Rs93.93 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.75 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.02 Billion |
ZhuZhou QianJin Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.40 | 2.56 | 2.31 |
| Quick Ratio | 1.13 | 2.18 | 1.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥620.33 Million | CN¥2.03 Billion | CN¥1.81 Billion |
ZhuZhou QianJin Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between ZhuZhou QianJin Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.17 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -2.6% |
| Total Assets | CN¥4.56 Billion |
| Market Capitalization | $782.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values ZhuZhou QianJin Pharmaceutical Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: ZhuZhou QianJin Pharmaceutical Co Ltd's assets decreased by 2.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2024)
The table below shows the annual total assets of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.56 Billion ≈ $666.73 Million |
-2.58% |
| 2023-12-31 | CN¥4.68 Billion ≈ $684.37 Million |
+1.19% |
| 2022-12-31 | CN¥4.62 Billion ≈ $676.34 Million |
+13.84% |
| 2021-12-31 | CN¥4.06 Billion ≈ $594.14 Million |
-3.98% |
| 2020-12-31 | CN¥4.23 Billion ≈ $618.79 Million |
+10.93% |
| 2019-12-31 | CN¥3.81 Billion ≈ $557.84 Million |
+9.78% |
| 2018-12-31 | CN¥3.47 Billion ≈ $508.13 Million |
+5.65% |
| 2017-12-31 | CN¥3.29 Billion ≈ $480.97 Million |
+8.40% |
| 2016-12-31 | CN¥3.03 Billion ≈ $443.69 Million |
+10.53% |
| 2015-12-31 | CN¥2.74 Billion ≈ $401.42 Million |
+23.07% |
| 2014-12-31 | CN¥2.23 Billion ≈ $326.16 Million |
+18.04% |
| 2013-12-31 | CN¥1.89 Billion ≈ $276.32 Million |
+14.78% |
| 2012-12-31 | CN¥1.65 Billion ≈ $240.75 Million |
+28.37% |
| 2011-12-31 | CN¥1.28 Billion ≈ $187.55 Million |
+13.58% |
| 2010-12-31 | CN¥1.13 Billion ≈ $165.13 Million |
-10.85% |
| 2009-12-31 | CN¥1.27 Billion ≈ $185.22 Million |
+19.48% |
| 2008-12-31 | CN¥1.06 Billion ≈ $155.02 Million |
-2.38% |
| 2007-12-31 | CN¥1.09 Billion ≈ $158.81 Million |
+30.95% |
| 2006-12-31 | CN¥828.73 Million ≈ $121.27 Million |
+3.82% |
| 2005-12-31 | CN¥798.23 Million ≈ $116.81 Million |
+0.72% |
| 2004-12-31 | CN¥792.53 Million ≈ $115.97 Million |
+88.12% |
| 2003-12-31 | CN¥421.29 Million ≈ $61.65 Million |
+17.07% |
| 2002-12-31 | CN¥359.87 Million ≈ $52.66 Million |
+8.14% |
| 2001-12-31 | CN¥332.78 Million ≈ $48.70 Million |
-- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more